Bradley Scott

10% OwnerXTL BIOPHARMACEUTICALS LTD (XTLB) · full profile →Form 4 · filed Mar 20, 2008
Net Buying
Open-Market Buys
$2.2M
Open-Market Sells
$0
Net Open-Market Flow
$2.2M
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2008Buy(P)156K$3.12$488K55.8M
Mar 18, 2008Buy(P)7K$3.12$21K3.0M
Mar 14, 2008Buy(P)16K$3.33$53K3.0M
Mar 14, 2008Buy(P)12K$3.32$40K3.0M
Mar 14, 2008Buy(P)247K$3.33$823K55.5M
Mar 14, 2008Buy(P)188K$3.32$624K55.6M
Mar 13, 2008Buy(P)9K$3.38$30K2.9M
Mar 13, 2008Buy(P)6K$3.37$20K2.9M
Mar 12, 2008Buy(P)9K$3.37$30K2.9M
Mar 12, 2008Buy(P)17K$3.35$58K2.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000909012-08-000455) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about XTLB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000909012-08-000455"
Ask your agent
Use Arkolith to summarize insider buying and selling at XTL BIOPHARMACEUTICALS LTD
over the last 90 days and cite the filings.